CRISPR-Cas生物传感用于病毒感染快速检测
本文综述了CRISPR-Cas系统原理及其联合生物传感策略在病毒检测中的最新研究进展。该策略具有高特异性、高灵敏度、操作简便和成本效益等优势,在病毒快速诊断领域展现重要潜力。文章还讨论了该策略面临的挑战并展望了未来发展方向。
要点
- CRISPR-Cas联合生物传感策略具有高特异性、高灵敏度、操作简便和成本效益优势。
- 该技术在病毒快速诊断领域展现显著潜力。
- 文章总结了CRISPR-Cas系统原理及病毒检测的最新研究进展。
核心结论
- CRISPR-Cas联合生物传感策略在病毒快速诊断领域具有显著潜力。
研究设计与样本
- 本文为综述,总结了CRISPR-Cas系统原理、新型生物技术及联合生物传感策略用于病毒检测的最新研究进展。
主要发现
- CRISPR-Cas联合生物传感策略表现出高特异性、高灵敏度、操作简便和成本效益等显著优势。
局限性
- 文章讨论了CRISPR-Cas生物传感策略面临的挑战并展望了未来发展方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With the frequent outbreaks of viral diseases globally, accurate and rapid diagnosis of viral infections is of significant importance for disease prevention and control. The CRISPR-Cas combined biosensing strategy, as an emergent nucleic acid detection technology, exhibits notable advantages including high specificity, elevated sensitivity, operational simplicity, and cost-effectiveness, thereby demonstrating significant potential in the domain of rapid viral diagnostics. This paper summarizes the principles of the CRISPR-Cas system, the novel biotechnologies, and the latest research progress in virus detection using the combined biosensing strategy. Additionally, this paper discusses the challenges faced by CRISPR-Cas biosensing strategies and outlines future development directions, which provides a reference for further research and clinical applications in the rapid diagnosis of viral infections.
引用
- Qiu Y, Chen S, Li J, et al. Crispr-cas biosensing for rapid detection of viral infection. Clin Chim Acta. 2024. PMID: 39638020. doi:10.1016/j.cca.2024.120071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。